ATTI 26° CONVEGNO NAZIONALE AIRM
17 February 2025
Vol. 42 No. 4 (2020)

[The management of benign thyroid diseases in medical radioprotection]

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
21
Views
34
Downloads

Authors

ABSTRACT. The thyroid gland is one of the most radiosensitive human organs. There are two major unwanted consequences from radiation to the thyroid in humans: hypothyroidism and neoplasia. In the system of dose limitation medical surveillance undoubtedly acquires obligations with regard to early tumor diagnosis (secondary prevention). On the basis of the risk coefficient of radioinduction of tumors established by international organizations, thyroidology should not be neglected. Following a wide range of doses of ionizing radiation, an increased risk of thyroid adenomas and nodules has been also observed in a variety of populations and settings, continuing for decades following exposure. Considerably less findings are available regarding functional thyroid disease including autoimmune diseases. In general, associations for these outcomes were fairly weak and significant radiation effect were most observed following high dose, particularly for hypothyroidism. Considerably less consistent findings are available regarding functional thyroid diseased including autoimmune diseases. The medical surveillance of exposed workers with thyroid pathology frequently involves delicate problems in particular concerning the differential diagnosis between benign and malignant nodules. In contrast to rare thyroid cancer, thyroid nodules are extremely common particularly among women. Thus, most thyroid nodules are benign, and it is important for a better outcome to identify those are likely to be malignant especially at an early stage. Therefore screening of all exposed workers is proposed since the beginning of their thyroid radiation exposure and an up to date diagnostic protocol is discussed. As a consequence of this justified strategy of secondary prevention a huge amount of thyroid nodules, mostly benign, is found involving problems of management especially from the point of view of medical surveillance of radiation protection. In this paper the author: - 1) Discusses the issues and suggests an up to date approach to diagnosis and management of nodular and functional thyroid diseases - 2) Identifies conditions which representing particular problems require a more restrictive judgement of fitness - 3) Intends to demonstrate that the proposed diagnostic protocol conciliates with due economy providing the right balance between effectiveness and costs, the real requirement of medical surveillance, reducing as far as possible undesirable effects such as damage from excessive protection and patient/ physician delay, which is extremely dangerous in the early diagnosis of tumors.

Altmetrics

Downloads

Download data is not yet available.

Citations

1) Non-malignant thyroid diseases after a wide range of radiation exposures. Elaine Ron, Alina Brenner Published in Radiation research DOI:10.1667/RR1953.1,2010 2) Imaizumi M, et al. Radiation Dose-Respone Relatinoships for Thyroid Nodules and Autoimmune Thyroid Diseases in Hiroshima and Nagasaki Atomic Bomb Survivors 55-58 Years After Tadiation Exposure. In JAMA 2006; Vol 295, No 9.
3) Gregory A. Brent, Environmental Exposures and Autoimmune Thyroid Disease Thyroid, 2010; 20(7): 755-762. DOI: https://doi.org/10.1089/thy.2010.1636
4) Ron EI, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr.5 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995 Mar; 141(3): 259-77. DOI: https://doi.org/10.2307/3579003
5) ICRP Publication 103: The recommendation Commission on Radiological Protection Annals of the ICRP, 2008; Vol 37: 2-4. 6) Virgili M, Strambi E, Trenta G, Moccaldi R. La sorveglianza della tiroide nel lavoro con radiazioni, in Atti IV Congreso de proteccion ragiologica de paises europeos del mediterraneo occidental. Barcelona, 1998.
7) American Thyroid Association Management Guideline, For Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer, 2015.
8) AACE/ACE/AME Medical Guidelines for Clinical Practice For The Diagnosis And Management Of Thyroid Nodules, Update 2016. 9) Strambi E, Virgili M. Thyroid nodules and medical fitness for radiation work: a case survey. In Atti International Congress IRPA 10th, Montreal, 1992.
10) Baschieri I. Fisiologia, patologie della tiroide, strumenti e criteri diagnostici. AIRM 1999; 29: 17-25.
11) Pacini F, Pinchera A, et al. Tumori della tiroide. Mediserve 2003; 116: 71-77.
12) Consensus statement AIT, AME, SIE, SIAPEC IAP for the classification and reporting of thyroid citology, 2014.
13) Virgili M, Strambi E, Trenta G. The Thyroid: medical surveillance of exposed workers. In Atti Internazional Congress IRPA 10th, Hiroshima, Japan 2000.
14) Davis S, Kopechy KJ, Hamilton TE, Onstad L. Hanford, Thyroid Disease Stidy Team 2204 Thyroid neoplasia, autoimmune thyroiditis and Hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 292: 2600-2613 PubMed| [Google Scholar]. 15) Mazzaferri EL. Management of a solitary thyroid nodule. New Engl J Mes 1993; 328: 553-9. DOI: https://doi.org/10.1001/jama.292.21.2600
16) Kindler S, Roser M, Below H, Hoffman W, Kohllmann T, Kramer A, Kirsch G, Volzke H. Thyroid disorders in employees of a nuclear plant. Thyroid 2006; 16: 2009-2017 [PubMed] [Google Scholar]. 17) Boice JD. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA 29: 1060-1063. DOI: https://doi.org/10.1001/jama.295.9.1060
18) Virgili M, Strambi E, Moccaldi R. The Thyroid: Medical Surveillance Of Exposed Workers. In Atti International Conference on radiation and medicine, Montpellier, France, 1995.
19) Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors. 2004; 161: 622-632. 20) Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, Maranghi M, Falcone R, Ramundo V, Cantisani V, Filetti S, Durante C. Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the "right" TIRADS. In: The Journal of Clinical Endocrinology And Metabolism. ISSN 0021-972X. 2019; 104: 1, pp. 95-102. DOI: https://doi.org/10.1210/jc.2018-01674

How to Cite



[The management of benign thyroid diseases in medical radioprotection]. (2025). Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 42(4), 281-291. https://doi.org/10.4081/gimle.477